---
title: "OmniAb surges 16% in regular trading on Lilly partnership worth $370M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296116920.md"
description: "OmniAb rose 16% during regular trading after announcing a global ion channel discovery deal with Eli Lilly worth up to $370M."
datetime: "2026-08-17T13:51:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296116920.md)
  - [en](https://longbridge.com/en/news/296116920.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296116920.md)
generator: "portal-rs"
---

# OmniAb surges 16% in regular trading on Lilly partnership worth $370M

OmniAb(OABI.US) 盘中时段涨超 16%，现报 3.954 美元。

消息面上，OmniAb 与礼来达成全球合作，共同开发离子通道发现项目。该交易包括首付款及高达 3.7 亿美元的里程碑付款和特许权使用费。公司同时上调 2026 年现金指引至 4900 万至 5300 万美元。该股盘中一度触及 52 周新高，但技术指标显示已处于超买状态。

### Related Stocks

- [OABI.US](https://longbridge.com/en/quote/OABI.US.md)

## Related News & Research

- [OmniAb to host Investor & Analyst Day, featuring executive presentations and xPloration platform demos](https://longbridge.com/en/news/298914397.md)
- [OmniAb to present at Nasdaq/LD Micro Summit Series](https://longbridge.com/en/news/297041629.md)
- [OmniAb (NASDAQ:OABI) Issues Quarterly Earnings Results, Beats Expectations By $0.07 EPS](https://longbridge.com/en/news/295310097.md)
- [OABI: Q2 2026 delivered strong revenue growth, clinical pipeline expansion, and new technology launches](https://longbridge.com/en/news/295401591.md)
- [Craig-Hallum Reaffirms Their Buy Rating on OmniAb (OABI)](https://longbridge.com/en/news/293184400.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**